FDA Inspection 1194275 — Barry Heller, M.D.
The FDA completed an inspection of Barry Heller, M.D. on December 19, 2022 in Long Beach, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 19, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Long Beach, CA (United States)
Additional Details
Clinical Investigator (CI)